Literature DB >> 9201246

Regulation of the release of tumour necrosis factor (TNF)alpha and soluble TNF receptor by gamma irradiation and interferon gamma in Ewing's sarcoma/peripheral primitive neuroectodermal tumour cells.

F van Valen1, V Kentrup-Lardong, B Truckenbrod, C Rübe, W Winkelmann, W W Jürgens.   

Abstract

This study analyses the production of tumour necrosis factor (TNF)alpha and soluble TNF receptor (sTNF-R) before and after exposure to gamma irradiation and interferon gamma (IFN gamma) in 12 cell lines derived from Ewing's sarcoma (ES)/peripheral primitive neuroectodermal tumours (pPNET). Supernatants from ES/pPNET cell cultures were tested in a TNF alpha-specific amplified enzyme-linked immunosorbent assay (ELISA), a bioassay, and sTNF-Rp55 and sTNF-Rp75 ELISA. The tumour cell lines released minimal amounts of TNF alpha, prominent amounts of sTNF-Rp55 (7/12 cell lines) and no sTNF-Rp75. Exposure to gamma irradiation (5 Gy) either induced (3/12) cell lines) or up-regulated (3/12 cell lines) TNF alpha release without changing sTNF-Rp55 and sTNF-Rp75 levels. Priming of cultures with recombinant human IFN gamma (rhIFN gamma) markedly enhanced TNF alpha secretion in the radiation-responsive cell lines and had no influence on sTNF-Rp55 and sTNF-Rp75 levels. rhIFN gamma affected the magnitude rather than the sensitivity of the radiation response. The TNF alpha secreted was bioactive, as shown by its cytotoxic effect of WEHI-164 cells, and neutralization of its activity by anti-TNF alpha monoclonal antibody. Herbimycin A (a tyrosine-specific protein kinase inhibitor) but not calphostin C (a protein kinase C inhibitor), H89 (a protein kinase A inhibitor), AA-COCF3 (a specific inhibitor of phospholipase A2) and MK-886 (a specific inhibitor of 5-lipoxygenase) abrogated gamma-irradiation-stimulated TNF alpha release. The antioxidants N-acetylcysteine, nordihydroguaiaretic acid and mepacrine dose-dependently inhibited gamma-irradiation-mediated TNF alpha production. Collectively our findings indicate that IFN gamma priming potentiates the secretion of bioactive TNF alpha by ES/pPNET cells in response to gamma irradiation without affecting sTNF-R release. The data suggest a requirement for protein tyrosine kinase activity and a role for reactive oxygen species in the gamma-irradiation-mediated intracellular signalling pathway leading to TNF alpha production.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9201246     DOI: 10.1007/bf01208634

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  40 in total

1.  Tumor necrosis factor type alpha, a potent inhibitor of endothelial cell growth in vitro, is angiogenic in vivo.

Authors:  M Fràter-Schröder; W Risau; R Hallmann; P Gautschi; P Böhlen
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

2.  Tumor necrosis factor inhibitor: purification, NH2-terminal amino acid sequence and evidence for anti-inflammatory and immunomodulatory activities.

Authors:  P Seckinger; E Vey; G Turcatti; P Wingfield; J M Dayer
Journal:  Eur J Immunol       Date:  1990-05       Impact factor: 5.532

3.  Interferon gamma and tumour necrosis factor alpha induce a synergistic antiproliferative response in human Ewing's sarcoma cells in vitro.

Authors:  F van Valen; W Winkelmann; S Burdach; U Göbel; H Jürgens
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

4.  Phospholipase A2 activation and autoinduction of tumor necrosis factor gene expression by tumor necrosis factor.

Authors:  D R Spriggs; M L Sherman; K Imamura; M Mohri; C Rodriguez; G Robbins; D W Kufe
Journal:  Cancer Res       Date:  1990-11-15       Impact factor: 12.701

5.  L-663,536 (MK-886) (3-[1-(4-chlorobenzyl)-3-t-butyl-thio-5-isopropylindol-2-yl]-2,2 - dimethylpropanoic acid), a novel, orally active leukotriene biosynthesis inhibitor.

Authors:  J Gillard; A W Ford-Hutchinson; C Chan; S Charleson; D Denis; A Foster; R Fortin; S Leger; C S McFarlane; H Morton
Journal:  Can J Physiol Pharmacol       Date:  1989-05       Impact factor: 2.273

6.  The antioxidant action of N-acetylcysteine: its reaction with hydrogen peroxide, hydroxyl radical, superoxide, and hypochlorous acid.

Authors:  O I Aruoma; B Halliwell; B M Hoey; J Butler
Journal:  Free Radic Biol Med       Date:  1989       Impact factor: 7.376

7.  Stimulation by Bt2cAMP of epidermal mucous metaplasia in retinol-pretreated chick embryonic cultured skin, and its inhibition by herbimycin A, an inhibitor for protein-tyrosine kinase.

Authors:  A Obinata; Y Akimoto; H Hirano; H Endo
Journal:  Exp Cell Res       Date:  1991-03       Impact factor: 3.905

8.  A comparison between two methods for measuring tumor necrosis factor in biological fluids.

Authors:  I M Garrelds; F J Zijlstra; C J Tak; I L Bonta; I Beckmann; S Ben-Efraim
Journal:  Agents Actions       Date:  1993

9.  IFN-gamma priming of monocytes enhances LPS-induced TNF production by augmenting both transcription and MRNA stability.

Authors:  M P Hayes; S L Freeman; R P Donnelly
Journal:  Cytokine       Date:  1995-07       Impact factor: 3.861

10.  Slow- and tight-binding inhibitors of the 85-kDa human phospholipase A2.

Authors:  I P Street; H K Lin; F Laliberté; F Ghomashchi; Z Wang; H Perrier; N M Tremblay; Z Huang; P K Weech; M H Gelb
Journal:  Biochemistry       Date:  1993-06-15       Impact factor: 3.162

View more
  4 in total

1.  Radiation increases invasion of gene-modified mesenchymal stem cells into tumors.

Authors:  Steven P Zielske; Donna L Livant; Theodore S Lawrence
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-10-11       Impact factor: 7.038

2.  TGF-beta1 influence on TNF-alpha production and sTNF-Rs shedding in a coculture of colon carcinoma cell spheroids with normal cells.

Authors:  Roman Paduch; Piotr Niedziela
Journal:  In Vitro Cell Dev Biol Anim       Date:  2009-03-20       Impact factor: 2.416

3.  Prolyl hydroxylase domain 3 influences the radiotherapy efficacy of pancreatic cancer cells by targeting hypoxia-inducible factor-1α.

Authors:  Li-Rui Tang; Jun-Xin Wu; Shao-Li Cai; Yun-Xia Huang; Xue-Qing Zhang; Wan-Kai Fu; Qing-Yang Zhuang; Jin-Luan Li
Journal:  Onco Targets Ther       Date:  2018-11-29       Impact factor: 4.147

4.  Monocyte Maturation Mediators Upregulate CD83, ICAM-1 and MHC Class 1 Expression on Ewing's Sarcoma, Enhancing T Cell Cytotoxicity.

Authors:  Emilie Biele; Sebastian J Schober; Carolin Prexler; Melanie Thiede; Kristina von Heyking; Hendrik Gassmann; Jennifer Eck; Busheng Xue; Stefan Burdach; Uwe Thiel
Journal:  Cells       Date:  2021-11-08       Impact factor: 6.600

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.